Lataa...

First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis

BACKGROUND & AIMS: We compared the efficacy and safety of different first-line (biologic-naïve) and second-line (prior exposure to tumor necrosis factor [TNF] antagonists) agents for treatment of moderate to severely active ulcerative colitis in a systematic review and network meta-analysis. MET...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Gastroenterol Hepatol
Päätekijät: Singh, Siddharth, Murad, Mohammad Hassan, Fumery, Mathurin, Dulai, Parambir S., Sandborn, William J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8022894/
https://ncbi.nlm.nih.gov/pubmed/31945470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2020.01.008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!